Buradasınız

Anasayfa » Content

Abdominal Histerektomide Vaginal Antisepsi için Klindamisin Krem

Intravaginal Clindamycin Cream Invaginal Antisepsis For Abdominal Hsyterectomy

Journal Name:

  • Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2000

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Our goal was to assess the effectiveness of vaginal clindamycin cream in reducing febrile morbidity after abdominal hysterectomy. Vaginal clindamycin cream was administered to 64 patients prior to hysterectomy for whom abdominal hysterectomy was planned between Jan 1999 and Jan 2000. Normal preoperative preparation were used for the 78 patients making up the control group. Febril morbidity degree records evaluated by curve. Febril morbidity was 9.3% for study group and 14.1 % for the control group. Incission site infection and cuff cellulitis were 4.6%, 4.6% for the stuidy group and 8.9% , 5.1 % for the control group in the same order. The findings were not statistically meaningful I. In conclusion , The use of preoperative vaginal clindamycine cream was not superior to normal preoperative procedure for lowering febril morbidity and postoperative infection.
Bookmark/Search this post with
Abstract (Original Language): 
Vaginal Klindamisin kremin abdominal histerektomi sonrası febril morbidititeyi azaltması açısından etkinliğinin değerlendirilmesi amacıyla Ocak 1999 ile Ocak 2000 tarihleri arasında abdominal lıisterektomi planlanan 64 hastaya lıisterektomi öncesi klindamisin vaginal krem uygulandı. Kontrol grubunu oluşturan 78 hastaya normal hazırlık yapıldı. Febril morbidite hasta derece kayıtlarından körlemesine değerlendirildi. Febril morbidite çalışma grubunun % 9.3 ' ünde , kontrol grubunun % 14.1 ' inde saptandı. İnsizyon yeri enfeksiyonu ve cuff celluliti sırası ile çalışma grubunda % 4.6, % 4.6 , kontrol grubunda ise %8.9, %5.l olrak saptandı. Verilerin karşılaştırması istatistiksel olarak anlamsızdı.Sonuç olarak preoperatif vaginal klindamisin krem febril morbidite ve postoperatif enfeksiyon azaltılmasında normal preoperatif hazırlıktan çok üstün değildir.
FULL TEXT (PDF): 
PDF icon arastirmax-abdominal-histerektomide-vaginal-antisepsi-icin-klindamisin-krem.pdf
  • 4
25-27
  • Turkish

REFERENCES

References: 

Cowart MR, Sea Uy MJ, Peterson HE. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 1982:144: 841 848.
2. Shapiro M, Munoz A, Tager IB, Schoenbaum SC, Polk BE. Risk factors for infectionat the operative site after abdominal or vaginal hysterectomy. NEngl J Med 1982; 307: 1661-1666.
3. Soper DE. Bacterial vaginosis and postoperative infection. Am J Obstet Gynecol 1993; 169: SDÜ Tıp Fakültesi Dergisi 2000; 7(4): 25-27
467-469.
4. Cnisa PJE, Foord R. The epidemiology of wound infection : a 10 year prospective study of 62939 wounds. Surg Clin North Am 1980; '60: 27-35.
5. Motiif GRG, Thompson JL, Stephens HD, Baer H. Quantitativeand qualitative effects of povidone- iodine liquid and gel on the anaerobic and aerobic flora of the female genital tract. Am J Obstet Gynecol 1980; 137: 432-438.
6. Duignan NM, Lowe PA. Pre-operative disinfection of the vagina . J Antimicrob Chemother 1975; 1: 117-/20.
7. Harnmill HA, Glainer HS, Townsend PJ, Meyers L. Development of clindamycin cream, for treatment of bacterial vaginosis. Obstet Gynecol 1990; 76: 1/8-123.
8. Schwartz WH, TanereeP. Suction drainage as an alternative to prph/actic antibiotics for hysterectomy. Obstet Gynecol 1975; 45: 305-310.
9. Haeri AD, Kloppers LL, Forder A A, Baillie P. Effect of different pre- operative vaginal preparations on morbidity of patients undergoing abdominal hysterectomy. S Afr Med J 1976; 50: 1984-/986.
10. Eason EL, Sampalis JS, Hammings R, Jhoseph L. Povidone - iodine gel vaginal antisepsis for abdominal hysterectomy. Am J Obstet Gynecol 1997; 176: Wll-1016. '
1/.National Center for Health Statistics. Advanced Data No. 264: National Hospital Discharge Survey. Hyattsville (MD) : Dept. Of Health Services; 1995.
12.Livengood CH, Thomasen JL, Hill GB. Bacterial vaginosis treatment with topical intravaginal clindamycin phosphate . Obstet Gynecol 1990; 76: 118-123. 13.Schmitt C, Sabel JD, Meriwether C. Bacterial vaginosis treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 1992;79:1020-3. 14.Hi/lier S, Krolm MA, Watts DH,Wolner-Hanssen P, Eschenbach D. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990;76:407-13.
15.Sweet RL. New approaches for the treatment of bacterial vaginosis. Am J Obstet Gynecol 1993,169:479 82.

Thank you for copying data from http://www.arastirmax.com